Oral ibandronate reduces activation frequency to healthy premenopausal levels in women with postmenopausal osteoporosis

被引：0
|
作者：
不详
机构：
来源：
CALCIFIED TISSUE INTERNATIONAL | 2006年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S155 / S156
页数：2
相关论文
共 50 条
  • [1] Treatment of postmenopausal osteoporosis with oral ibandronate reduces activation frequency to healthy premenopausal levels.
    Recker, RR
    Davies, KM
    Barger-Lux, MJ
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S399 - S399
  • [2] PREVENTION OF OSTEOPOROSIS IN PREMENOPAUSAL AND POSTMENOPAUSAL WOMEN
    SAGRAVES, R
    AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION, 1991, 55 (02) : 158 - 166
  • [3] EDUCATION STATUS AND INFORMATION LEVELS OF PREMENOPAUSAL AND POSTMENOPAUSAL WOMEN ABOUT OSTEOPOROSIS
    Okumus, M.
    Ceceli, E.
    Tasbas, O.
    Kocaoglu, S.
    Akdogan, S.
    Borman, P.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : 256 - 257
  • [4] Oral daily ibandronate prevents bone loss in early postmenopausal women without osteoporosis
    McClung, MR
    Wasnich, RD
    Recker, R
    Cauley, JA
    Chesnut, CH
    Ensrud, KE
    Burdeska, A
    Mills, T
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (01) : 11 - 18
  • [5] EFFICACY OF ONCE-MONTHLY ORAL BISPHOSPHONATES (IBANDRONATE AND RISEDRONATE) IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS
    Epstein, S.
    McCloskey, E.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 : 146 - 146
  • [6] Daily oral ibandronate prevents bone loss in postmenopausal women without osteoporosis.
    McClung, M
    Wasnich, RD
    Recker, R
    Cauley, JA
    Ensrud, K
    Burdeska, A
    Mahoney, P
    Hughes, C
    Chesnut, C
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S157 - S157
  • [7] Ibandronate (Boniva) for treatment and prevention of osteoporosis in postmenopausal women
    Ference, JD
    Wilson, SA
    AMERICAN FAMILY PHYSICIAN, 2006, 73 (02) : 305 - 306
  • [8] Efficacy and safety of oral weekly ibandronate in the treatment of postmenopausal osteoporosis
    Cooper, C
    Emkey, RD
    McDonald, RH
    Hawker, G
    Bianchi, G
    Wilson, K
    Schimmer, RC
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (10): : 4609 - 4615
  • [9] Weekly dosing of oral ibandronate is effective in the prevention of postmenopausal osteoporosis
    Felsenberg, D
    Christiansen, C
    Cerwinski, E
    Burdeska, A
    Jonkanski, I
    Meinert, R
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S16 - S17
  • [10] Oral and intravenous ibandronate in the management of postmenopausal osteoporosis: A comprehensive review
    Reginster, JY
    CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (28) : 3711 - 3728
12345